Allakos Revenue and Competitors



Total Funding



Estimated Revenue & Valuation

  • Allakos's estimated annual revenue is currently $6.5M per year.(i)
  • Allakos received $100.0M in venture funding in December 2017.
  • Allakos's estimated revenue per employee is $48,947
  • Allakos's total funding is $162.4M.
  • Allakos's current valuation is $415M. (January 2022)

Employee Data

  • Allakos has 133 Employees.(i)
  • Allakos grew their employee count by 2% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
Add Company

Allakos Inc. is a publicly traded clinical-stage biopharmaceutical company developing first-in-class antibody-based therapeutics to treat allergic and inflammatory diseases.

keywords:Biotechnology,Cleantech,Healthcare,Marketing,Pharmaceuticals,Wind Power


Total Funding


Number of Employees


Revenue (est)


Employee Growth %





Allakos News

2022-04-20 - ALLAKOS INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)

(b) On April 15, 2022 , Mark Asbury informed Allakos Inc. (the "Company") of his decision to retire from his position as Chief Legal Officer and...

2022-04-20 - Ambys Medicines Expands Leadership Team with Key ...

Before Allakos, John held financial planning and analytics positions at Jaguar Health, BioMarin Pharmaceuticals, and Avinger, Inc. Earlier in...

2022-04-13 - Analysts Anticipate Allakos Inc. (NASDAQ:ALLK) to Announce ...

Allakos logo Equities analysts forecast that Allakos Inc. (NASDAQ:ALLK – Get Rating) will announce earnings of ($1.71) per share for the...

2019-09-08 - SG Americas Securities LLC Acquires 1,040 Shares of Allakos Inc (NASDAQ:ALLK)

SG Americas Securities LLC increased its stake in shares of Allakos Inc (NASDAQ:ALLK) by 27.5% during the 2nd quarter, according to the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding

Allakos Funding

DateAmountRoundLead InvestorsReference
2017-12-14$100.0MANew Enterprise AssociatesArticle